Viking Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. 

CEO
Brian Lian
CEOBrian Lian
Employees
36
Employees36
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
36
Employees36

VKTX Key Statistics

Market cap
2.74B
Market cap2.74B
Price-Earnings ratio
-16.16
Price-Earnings ratio-16.16
Dividend yield
Dividend yield
Average volume
4.74M
Average volume4.74M
High today
$25.18
High today$25.18
Low today
$23.84
Low today$23.84
Open price
$24.78
Open price$24.78
Volume
5.67M
Volume5.67M
52 Week high
$81.73
52 Week high$81.73
52 Week low
$18.92
52 Week low$18.92

VKTX News

Simply Wall St 4d
Viking Therapeutics Valuation: Are Investors Paying Too Much for Future Growth?

Advertisement What’s Behind Viking Therapeutics' Recent Moves? If you hold shares of Viking Therapeutics (VKTX) or are thinking about jumping in, the stock’s...

Viking Therapeutics Valuation: Are Investors Paying Too Much for Future Growth?

Analyst ratings

94%

of 16 ratings
Buy
93.8%
Hold
6.3%
Sell
0%

People also own

Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.